Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.

Literature DB >> 859101

Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.

J G Wagner.

Abstract

Mesh：

Substances：

Year: 1977 PMID： 859101 DOI： 10.1007/BF01066219

Source DB: PubMed Journal: J Pharmacokinet Biopharm ISSN： 0090-466X

× No keyword cloud information.

29 in total

1. Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

Authors: J R Koup; D J Greenblatt; W J Jusko; T W Smith; J Koch-Weser
Journal: J Pharmacokinet Biopharm Date: 1975-06

2. Pharmacokinetics of diphenhydramine in man.

Authors: K S Albert; M R Hallmark; E Sakmar; D J Weidler; J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1975-06

3. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors: J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1976-10

4. General theory for rapidly establishing steady state drug concentrations using two consecutive constant rate intravenous infusions.

Authors: D P Vaughan; G T Tucker
Journal: Eur J Clin Pharmacol Date: 1975-12-19 Impact factor: 2.953

5. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers.

Authors: O Eriksson; H Kjellman; A Pilbrant; M Schannong
Journal: Eur J Clin Pharmacol Date: 1974-08-23 Impact factor: 2.953

6. Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.

Authors: W G Kramer; R P Lewis; T C Cobb; W F Forester; J A Visconti; L A Wanke; H G Boxenbaum; R H Reuning
Journal: J Pharmacokinet Biopharm Date: 1974-08

7. Comparison of ampicillin and hetacillin pharmacokinetics in man.

Authors: W J Jusko; G P Lewis
Journal: J Pharm Sci Date: 1973-01 Impact factor: 3.534

8. The specificity of the digoxin radioimmunoassay procedure.

Authors: R G Stoll; M S Christensen; E Sakmar; J G Wagner
Journal: Res Commun Chem Pathol Pharmacol Date: 1972-11

9. Pharmacokinetic profile of sulfisoxazole following intravenous, intramuscular, and oral administration to man.

Authors: S A Kaplan; R E Weinfeld; C W Abruzzo; M Lewis
Journal: J Pharm Sci Date: 1972-05 Impact factor: 3.534

10. Pharmacokinetics--uses and abuses.

Authors: P J Fell; M T Stevens
Journal: Eur J Clin Pharmacol Date: 1975-04-04 Impact factor: 2.953

18 in total

1. Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects.

Authors: F B Eatman; W A Colburn; H G Boxenbaum; H N Posmanter; R E Weinfeld; R Ronfeld; L Weissman; J D Moore; M Gibaldi; S A Kaplan
Journal: J Pharmacokinet Biopharm Date: 1977-10

2. Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.

Authors: J G Wagner; J W Ayres
Journal: J Pharmacokinet Biopharm Date: 1977-10

Pharmacokinetic data. Pharmacokinetic parameters estimated from intravenous data by uniform methods and some of their uses.

1. Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

2. Pharmacokinetics of diphenhydramine in man.

3. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

4. General theory for rapidly establishing steady state drug concentrations using two consecutive constant rate intravenous infusions.

5. Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers.

6. Pharmacokinetics of digoxin: comparison of a two- and a three-compartment model in man.

7. Comparison of ampicillin and hetacillin pharmacokinetics in man.

8. The specificity of the digoxin radioimmunoassay procedure.

9. Pharmacokinetic profile of sulfisoxazole following intravenous, intramuscular, and oral administration to man.

10. Pharmacokinetics--uses and abuses.

1. Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjects.

2. Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.

3. Mean residence time in peripheral tissue.

4. Estimation of absolute bioavailability assuming steady state apparent volume of distribution remains constant.

5. A standard approach to compiling clinical pharmacokinetic data.

6. Variability in derived parameters of furosemide pharmacokinetics.

7. Curve fitting and modeling in pharmacokinetics: a response.

8. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.

9. Stereoselective systemic disposition of ibuprofen enantiomers in the dog.

10. Determinants of bumetanide response in the dog: effect of probenecid.